Most academic institutions have no policy on clinical trial transparency

New research shows that most US academic institutions do not have policies to ensure clinical trials run by their researchers are registered and results reported. A survey of 366 universities in the US uncovered that less than half have a policy on registration of clinical trials (43%) and only around a third (35%) have a […]

3rd May 2018|

Do charities and governments ensure clinical trial researchers report results? Most don’t.

Most of the world’s largest charities and government bodies who fund clinical trials don’t ask that the results from these trials are reported.

An audit of the stated transparency polices of the 18 philanthropic and public bodies that spend the most money on clinical research has found that most do not require researchers to report results […]

24th April 2018|

Unreported Clinical Trial of the Week

The AllTrials campaign is shining a spotlight on clinical trials that haven’t published results, one per week from now on in the BMJ. Read more about this new series in the BMJ.

The trials we write about will be one of those flagged by the FDAAA Compliance Tracker and, as of 14 September 2018, the EU TrialsTracker […]

29th March 2018|

Seizing the moment

Hello hello,

I hope you’ve seen our new tool, the FDAAA TrialsTracker, which identifies every individual clinical trial that fails to report its results, live online. Now everyone can see the individual institutes, companies and researchers responsible for unreported trials, the very day they go overdue.

Three weeks ago we highlighted just one of these overdue […]

15th March 2018|

We’re writing weekly to the FDA

With the launch of the FDAAA Trials Tracker, we wrote an open letter to the FDA asking them to act on the unreported trials being publically flagged. We’re writing to them every week with the list of trials in breach of the FDAAA Final Rule as well as how much the FDA could have levied […]

5th March 2018|

Open letter to the FDA

Dr Scott Gottlieb
Food and Drug Administration

16th February 2018

Dear Dr Gottlieb

As the body responsible for compliance with the FDA Amendments Act 2007, you have the power to sanction those who break this law, including the levy of fines up to $10,000 a day against clinical trial sponsors who fail to publish their trial results on […]

19th February 2018|

Giving evidence to House of Commons Science and Technology Committee

Síle Lane and Ben Goldacre gave evidence to the House of Commons Science and Technology Committee’s inquiry into research integrity along with Dr Simon Kolstoe.

Watch the session:

Publication bias in clinical trials is the most thoroughly researched aspect of research integrity – having been discussed in detail for over 30 years. And now the area with quite […]

5th December 2017|

AllTrials review of pharmaceutical company policies on clinical trial transparency

Our review of the world’s largest pharmaceutical companies’ trial registration and reporting policies is now published in the BMJ. This is the first time anyone has systematically examined and compared published company policies on trial transparency.

We found:

Most of the largest companies, though not all, have some sort of publicly stated policy about registering and reporting results from current […]

27th July 2017|

“No more excuses” as major global research funders take strong lead on clinical trial transparency

Some of the world’s largest research funders and NGOs today agreed to adopt the WHO’s strong standards on clinical trial transparency. This means all clinical trials they fund or support will be registered and the results reported.

In a joint statement, nine major funders including Médecins Sans Frontières, the Bill & Melinda Gates Foundation, the Indian Council of Medical […]

17th May 2017|

Canadians: act now for clinical trial transparency

Canadians: now is our best chance to get Health Canada to take a big step towards making results from all clinical trials available.

Back in 2014, the Canadian government passed the Protecting Canadians from Unsafe Drugs Act, commonly known as Vanessa’s Law. Following pressure from AllTrials, the law gave the Minister of Health the authority to […]

16th May 2017|